Delivery Order SPE2DB22D3501-SPE2DB25FVN46
Award Date
5/5/25
Potential Completion Date
5/6/25
Potential Value
$2.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,072.25 firm fixed-price delivery order contract provides for PEGASYS 180 MCG/ML VIALML, with a completion date of February 4, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,330.94, is for the delivery of PEGASYS 180 MCG/ML VIALML, a medical product. The contract is a Firm Fixed Price Delivery Order, with a period of performance extending to November 19, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,064.99 firm fixed price delivery order is for the supply of PEGASYS 180 MCG/ML VIALML, with a completion date of December 10, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award is for the delivery of PEGASYS 180 MCG/ML VIAL medical products to the Defense Logistics Agency (DLA). The contract, valued at $4,522.80, was awarded to the prime contractor AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price pricing type and an ultimate completion date of December 3, 2024. This contract is not designated as a set-aside. AmerisourceBergen holds a...
The federal contract award is a Delivery Order valued at $12,023.01 issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PEGASYS 180 MCG/0.5 ML SYRINGE 0.5ML medical supplies. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award, valued at $4,055.25, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under an Indefinite Delivery Contract (IDC) designated as SPE2DX, which provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. The contract covers the delivery of PEGASYS 180 MCG/ML VIALML, a...
This federal contract award is a delivery order (SPE2DX15D1053|SPE2DX25F6CMP) valued at $14,657.17 issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of the medical product "PEGASYS 180 MCG/0.5 ML SYRINGE 0.5ML" with an ultimate completion date of October 30, 2024. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,778.35, is for the delivery of the drug PEGASYS 180 MCG/ML VIALML. This contract is not set aside and is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen Drug Corp and DLA, valued at $999,999,999.00, which provides comprehensive global...
This federal contract award, SPE2DX22D0049|SPE2D825FA4EG, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $7,978.11 firm fixed-price delivery order supports the agency's medical supply chain requirements, providing a range of pharmaceutical products and medical supplies to military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The contract has an ultimate completion date of February 25, 2025....
This federal contract award SPE2DX22D0029|SPE2D825F26GT was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,651.68 firm fixed price delivery order contract is for the supply of various pharmaceutical products and medical supplies, including medications across multiple therapeutic domains such as diabetes, neurology, pain management, and antibiotics. The contract is not set aside and is part of...